These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Aprepitant--where do we stand in the control of chemotherapy-induced nausea and vomiting? Sarcev T; Secen N; Zaric B; Milovancev A J BUON; 2008; 13(3):333-9. PubMed ID: 18979546 [TBL] [Abstract][Full Text] [Related]
4. Aprepitant (EMEND): the role of substance P in nausea and vomiting. Prommer E J Pain Palliat Care Pharmacother; 2005; 19(3):31-9. PubMed ID: 16219609 [TBL] [Abstract][Full Text] [Related]
5. [Prevention of nausea and vomiting. Aprepitant, the first therapeutic acting NK-1 receptor antagonist]. Nieber K; Schoppmeyer K Pharm Unserer Zeit; 2007; 36(5):373-80. PubMed ID: 17722144 [No Abstract] [Full Text] [Related]
6. Fosaprepitant: a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting. Navari RM Expert Rev Anticancer Ther; 2008 Nov; 8(11):1733-42. PubMed ID: 18983233 [TBL] [Abstract][Full Text] [Related]
7. Chemotherapy-induced nausea and vomiting. Lohr L Cancer J; 2008; 14(2):85-93. PubMed ID: 18391612 [TBL] [Abstract][Full Text] [Related]
8. Chemotherapy-induced nausea and vomiting: state of the art in 2006. Schwartzberg L J Support Oncol; 2006 Feb; 4(2 Suppl 1):3-8. PubMed ID: 16499138 [TBL] [Abstract][Full Text] [Related]
9. [Guidelines for prophylaxis and treatment of chemotherapy-induced nausea and vomiting]. Durand JP; Madelaine I; Scotté F Bull Cancer; 2009 Oct; 96(10):951-60. PubMed ID: 19734117 [TBL] [Abstract][Full Text] [Related]
10. Chemotherapy-induced nausea and vomiting: clinician and patient perspectives. Schwartzberg LS J Support Oncol; 2007 Feb; 5(2 Suppl 1):5-12. PubMed ID: 17366928 [TBL] [Abstract][Full Text] [Related]
11. [Croatian guideliness for prevention of chemotherapy induced nausea and vomiting]. Tomek R; Vrdoljak E; Vrbanec D; Nemet D; Matković V; Plestina S; Gugić D; Dintinjana RD; Bolanca A; Samarzija M; Petković M Lijec Vjesn; 2009; 131(3-4):49-53. PubMed ID: 19514248 [TBL] [Abstract][Full Text] [Related]
12. Chemotherapy-induced nausea and vomiting in the treatment of gastrointestinal tumors and secondary prophylaxis with aprepitant. Abbrederis K; Lorenzen S; Rothling N; Ihbe-Heffinger A; Schuster T; Peschel C; Lordick F Onkologie; 2009 Feb; 32(1-2):30-4. PubMed ID: 19209016 [TBL] [Abstract][Full Text] [Related]
13. Update on the management of chemotherapy-related nausea and vomiting: an emphasis on the new class of agents--neurokinin-1 receptor antagonists. Gralla R Clin Adv Hematol Oncol; 2006 Jul; 4(7):507-8. PubMed ID: 17147235 [No Abstract] [Full Text] [Related]
14. [Management of emesis in cancer patients]. Slimane K; Perez A; Ruffié P; di Palma M Bull Cancer; 2004 May; 91(5):403-8. PubMed ID: 15281279 [TBL] [Abstract][Full Text] [Related]
15. Anti-emetic therapy in cancer chemotherapy: current status. Herrstedt J; Dombernowsky P Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):143-50. PubMed ID: 17697032 [TBL] [Abstract][Full Text] [Related]
16. Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting: beyond prevention of acute emesis. Slatkin NE J Support Oncol; 2007 May; 5(5 Suppl 3):1-9. PubMed ID: 17566383 [TBL] [Abstract][Full Text] [Related]
17. New drug helps relieve chemotherapy-related symptoms. FDA Consum; 2003; 37(4):3. PubMed ID: 12971326 [No Abstract] [Full Text] [Related]
18. The role of neurokinin-1 receptor antagonists for the management of postoperative nausea and vomiting. Apfel CC; Malhotra A; Leslie JB Curr Opin Anaesthesiol; 2008 Aug; 21(4):427-32. PubMed ID: 18660647 [TBL] [Abstract][Full Text] [Related]
19. Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations. Jordan K; Sippel C; Schmoll HJ Oncologist; 2007 Sep; 12(9):1143-50. PubMed ID: 17914084 [TBL] [Abstract][Full Text] [Related]
20. [Prevention and treatment of chemotherapy-induced digestive toxicities]. Boige V; Ducreux M Bull Cancer; 2001 Feb; 88(2):163-73. PubMed ID: 11257591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]